600511 国药股份
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
2019/12
人民币(K¥)
经营活动产生之现金流量净额2,726,6572,395,1231,957,4511,301,6711,776,070
投资活动产生之现金流量净额(129,311)(152,319)(122,991)(56,465)14,662
筹资活动产生之现金流量净额(632,176)(639,573)(745,962)(730,612)(1,216,823)
汇率变动对现金及现金等价物的影响------(19)(677)
现金及现金等价物净增加/(减少)1,965,1701,603,2321,088,497514,574573,231
期初现金及现金等价物余额8,833,1487,229,9166,141,4195,626,8455,053,613
期末现金及现金等价物余额10,798,3188,833,1487,229,9166,141,4195,626,845